Docetaxel and Gemcitabine

DRUG2 trials

Sponsors

University of Southern California, Sanofi

Conditions

Non-small Cell Lung CancerOvarian CarcinomaPeritoneal Neoplasms

Phase 2

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

CompletedNCT00183794

University of Southern CaliforniaOvarian Carcinoma, Peritoneal Neoplasms

Start: 2002-11-30End: 2010-05-31Updated: 2014-05-22

Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.

CompletedNCT00425191

SanofiNon-small Cell Lung Cancer

Start: 2002-07-31Updated: 2009-12-07